473 related articles for article (PubMed ID: 28686819)
1. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
2. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
Girand HL; Litkowiec S; Sohn M
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
[TBL] [Abstract][Full Text] [Related]
3. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
4. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
5. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD.
Liu X; Shah V; Kubilis P; Xu D; Bussing R; Winterstein AG
J Atten Disord; 2019 Jan; 23(2):140-148. PubMed ID: 26269095
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
8. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Chen CY; Gerhard T; Winterstein AG
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy.
Lohr WD; Jawad K; Feygin Y; Le J; Creel L; Pasquenza N; Williams PG; Jones VF; Myers J; Davis DW
Psychiatr Serv; 2022 May; 73(5):510-517. PubMed ID: 34470507
[TBL] [Abstract][Full Text] [Related]
10. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
Fullerton CA; Epstein AM; Frank RG; Normand SL; Fu CX; McGuire TG
Psychiatr Serv; 2012 Feb; 63(2):115-21. PubMed ID: 22302327
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
13. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Rowles BM; Findling RL
Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
[TBL] [Abstract][Full Text] [Related]
14. Trends in the prescribing of psychotropic medications to preschoolers.
Zito JM; Safer DJ; dosReis S; Gardner JF; Boles M; Lynch F
JAMA; 2000 Feb; 283(8):1025-30. PubMed ID: 10697062
[TBL] [Abstract][Full Text] [Related]
15. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
Schubart JR; Camacho F; Leslie D
Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
18. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
[TBL] [Abstract][Full Text] [Related]
20. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
